TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Debt | ₹54 Cr | ₹18 Cr | ₹7.69 Cr | ₹2.45 Cr |
What is the latest Total Debt ratio of TRIDENT LIFELINE ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹54 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹7.69 Cr |
| Mar2022 | ₹2.45 Cr |
How is Total Debt of TRIDENT LIFELINE Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹54 Cr | 193.49 | |
| Mar2024 | ₹18 Cr | 139.40 | |
| Mar2023 | ₹7.69 Cr | 213.49 | |
| Mar2022 | ₹2.45 Cr | - | |
Compare Total Debt of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹320.1 Cr | 5.9% | -11.5% | -7.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 5.9% |
-11.5% |
-7.2% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses